Search - tctmd.com

Displaying 61 - 80 of 459

Sort: Relevancy | Date

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

News Daily News

FDA: Abbott Recalls NC Trek RX and NC Traveler Coronary Catheters

Shelley Wood

February 24, 2020

News Daily News

Balloon-Free PCI for SVG Stenosis Offers Ongoing Advantages: DIVA

Caitlin E. Cox

February 11, 2020

News Daily News

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Michael O'Riordan

November 29, 2019

News Daily News

CMS Finalizes Rule Allowing Reimbursement of PCI in Ambulatory Centers

Todd Neale

November 04, 2019

News Daily News

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

L.A. McKeown

October 09, 2019

News Daily News

CMS Weighs Reimbursement for Out-of-Hospital Coronary Interventions

Caitlin E. Cox

September 20, 2019

News Daily News

PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis

Caitlin E. Cox

August 15, 2019

News Daily News

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

Caitlin E. Cox

July 30, 2019

News Daily News

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

Shelley Wood

July 23, 2019

News Daily News

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

Yael L. Maxwell

June 18, 2019

News Daily News

Supervised Exercise Plus Angioplasty Best for Intermittent Claudication: Meta-analysis

Todd Neale

June 03, 2019

News Daily News

PCI ‘Center of Excellence’? Insurers’ Designation May Not Mean Better Outcomes

Todd Neale

May 20, 2019

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

L.A. McKeown

March 01, 2019

News Daily News

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

L.A. McKeown

February 20, 2019

News Daily News

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

L.A. McKeown

February 19, 2019

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

L.A. McKeown

February 13, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

News Daily News

Interventional Career? Female Fellows Repelled by ‘Old Boys Club,’ Radiation Risks, and Physical Demands

Yael L. Maxwell

January 17, 2019

Advertisement

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

FDA: Abbott Recalls NC Trek RX and NC Traveler Coronary Catheters

Balloon-Free PCI for SVG Stenosis Offers Ongoing Advantages: DIVA

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

CMS Finalizes Rule Allowing Reimbursement of PCI in Ambulatory Centers

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

CMS Weighs Reimbursement for Out-of-Hospital Coronary Interventions

PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

Supervised Exercise Plus Angioplasty Best for Intermittent Claudication: Meta-analysis

PCI ‘Center of Excellence’? Insurers’ Designation May Not Mean Better Outcomes

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

Interventional Career? Female Fellows Repelled by ‘Old Boys Club,’ Radiation Risks, and Physical Demands

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content